Cargando…
Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I
AIMS : To estimate the cost-effectiveness of using the cardiac specific marker high-sensitivity troponin-I (hsTnI) for assessing cardiovascular disease (CVD) risk in a general population. METHODS AND RESULTS : A discrete-event simulation model was developed from a societal perspective of a low-risk...
Autores principales: | Jülicher, Paul, Varounis, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071558/ https://www.ncbi.nlm.nih.gov/pubmed/33502472 http://dx.doi.org/10.1093/ehjqcco/qcab005 |
Ejemplares similares
-
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
por: Blankenberg, Stefan, et al.
Publicado: (2016) -
High-sensitivity troponins and mortality in the general population
por: McEvoy, John W, et al.
Publicado: (2023) -
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population
por: Kimenai, Dorien M, et al.
Publicado: (2021) -
High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020) -
The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis
por: Jülicher, Paul, et al.
Publicado: (2017)